title: KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab (Br J Surg 2012; 99: 1575-1582).
authors.affiliation: Department of Surgery and Hepato-biliary and Pancreas Centre, University Hospitals of Geneva, 1211 Geneva 14, Switzerland. gilles.mentha@hcuge.ch
authors.forename: G
authors.initials: G
authors.lastname: Mentha
mesh_terms: D015179:Colorectal Neoplasms / Q000235:genetics*; D005260:Female; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary*; D008297:Male; D009154:Mutation / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*
chemical_list: C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf